LONDON, February 6, 2015 /PRNewswire/ --
Investor-Edge.com has issued free earnings coverage on Janus Capital Group Inc. (NYSE: JNS). On January 22, 2015, the company reported its financial results for Q4 FY14 and full year FY14 (period ended December 31, 2014). Click on http://get.Investor-Edge.com/pdf/?c=Janus%20Capital&d=06-Feb-2015&s=JNS to read our free earnings review on Janus Capital Group Inc. (JCG). During Q4 FY14 and FY14, the company's total revenue was $254.8 million and $953.2 million, respectively. Additionally, the company reported net income attributable to JCG's common shareholders of $45.2 million, or $0.24 per diluted share, in the reported quarter and $149.3 million, or $0.81 per diluted share, in FY14. Our free coverage report can be accessed at:
http://get.Investor-Edge.com/pdf/?c=Janus%20Capital&d=06-Feb-2015&s=JNS
Earnings Overview
During Q4 FY14, JCG's total revenue increased by $28.6 million from $226.2 million in Q4 FY13. The company's total revenues during Q4 FY14 outperformed Bloomberg analysts' forecast of $244.3 million. JCG reported average assets under management during Q4 FY14 of $179.2 billion compared to $170.3 billion in Q4 FY13. Furthermore, the company's operating expenses increased to $174.3 million in the reported quarter from $159.2 million in Q4 FY13. Free research on JNS can be downloaded in PDF format at:
http://get.Investor-Edge.com/pdf/?c=Janus%20Capital&d=06-Feb-2015&s=JNS
In Q4 FY14, JCG's operating income was $80.5 million as compared to $67.0 million in Q4 FY13. During the reported quarter, the company's net income attributable to JCG's common shareholders increased by $6.9 million, or $0.03 per diluted share, from $38.3 million, or $0.21 per diluted share, in Q4 FY13. Analysts from Bloomberg had expected net income attributable to JCG's common shareholders of $39.2 million, or $0.21 per diluted share, in Q4 FY14. Additionally, JCG recorded cash flow from operations of $88.4 million, during Q4 FY14, compared with $92.1 million in Q4 FY13.
During the reported quarter, JCG repurchased 1.56 million shares of its common stock at an average price of $14.83 per share for $23.1 million. Sign up and read the free analyst's notes on JNS at:
http://get.Investor-Edge.com/pdf/?c=Janus%20Capital&d=06-Feb-2015&s=JNS
In FY14, JCG's total revenue grew by $79.3 million from $873.9 million in FY13. The company's total revenues during FY14 outperformed Bloomberg analysts' forecast of $943.1 million. JCG's average assets under management came at $175.8 billion in FY14 compared to $165.4 billion in FY13. Additionally, the company's operating expenses in FY14 increased to $663.5 million from $634.8 million in FY13.
JCG's operating income for FY14 came in at $289.7 million as opposed to $239.1 million reported in FY13. In FY14, the company's net income attributable to JCG's common shareholders increased by $34.6 million, or $0.19 per diluted share, from $114.7 million, or $0.62 per diluted share, in FY13. Analysts from Bloomberg had expected net income attributable to JCG's common shareholders of $146.0 million, or $0.78 per diluted share, in FY14. Additionally, in FY14, the company recorded cash flow from operations of $218.4 million compared with $224.1 million in FY13.
As of December 31, 2014, JCG had cash and investments balance of $796.5 million and outstanding debt of $450.5 million. Furthermore, on the same date, the company had total assets under management of $183.1 billion compared to $173.9 billion as of December 31, 2013. Visit Investor-Edge and access the latest research on JNS at:
http://get.Investor-Edge.com/pdf/?c=Janus%20Capital&d=06-Feb-2015&s=JNS
On January 15, 2015, JCG's board of directors announced a quarterly cash dividend of $0.08 per share, which is payable on February 27, 2015 to its shareholders of record at the close of business on February 13, 2015.
Stock Performance
On the day of the earnings release, January 22, 2015, JCG's stock rallied 12.96% to end the session at $18.39. Since then, the stock has moved both ways with losses outperforming gains. However, on the last close, Thursday, February 05, 2015, the company's shares finished 1.92% higher at $18.06, after vacillating between $17.64 and $18.38. A total of 2.37 million shares were traded which was below its three months average volume of 3.72 million shares. Over the last one month and over the previous three months, the company's shares have surged 14.81% and 20.56%, respectively. Additionally, the stock has rallied 75.00% in the past one year. Shares in JCG are trading above their 50-day and 200-day moving averages of $16.39 and $13.61, respectively. Furthermore, the stock traded at a PE ratio of 22.12 and has a Relative Strength Index (RSI) of 57.13.
Sneak Peek to Corporate Insider Trading
In the last one month, there were five corporate transactions made by five insiders. Between January 28, 2015 and February 02, 2015, a total of 368,990 shares have been disposed at an average price of $16.05 per share and for a total value of $5.92 million. The following are few of the aforesaid transactions: on January 28, 2015, Dai Ichi Life Insurance Co. Ltd, a 10% stakeholder in JCG, sold 295,850 shares at a price of $15.72 per share. On February 02, 2015, Augustus Cheh, Executive Vice President & President of Janus International, and Bruce L. Koepfgen, President at JCG, disposed 39,529 and 22,938 shares, respectively, at a price of $17.41 per share. Complimentary in-depth research on JNS is available at:
http://get.Investor-Edge.com/pdf/?c=Janus%20Capital&d=06-Feb-2015&s=JNS
About Investor-Edge.com
At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Investor-Edge
